News

Northleaf Capital Partners Invests in CCM Hockey with Altor

Northleaf Capital Partners Invests in CCM Hockey with Altor

Northleaf Capital Partners Announces Investment in CCM Hockey

Northleaf Capital Partners, a prominent player in the realm of global private markets investment, has successfully completed a significant investment in CCM Hockey. This investment showcases Northleaf's strategic collaboration with Altor Equity Partners, another distinguished firm within the private equity sector. While financial specifics concerning the transaction remain undisclosed, the partnership highlights a shared vision of growth and innovation in hockey equipment.

About CCM Hockey

Founded in 1899, CCM Hockey stands as a beacon within the sports equipment industry, particularly focused on hockey. The company is renowned for its high-quality design, manufacturing, and distribution of hockey equipment, which encompasses skates, sticks, protective gear, helmets, and goalie equipment. CCM’s presence spans over 40 countries globally, making it a household name among professional hockey players, including many stars from the NHL and PWHL.

Commitment to Growth and Innovation

Michael Flood, the Head of Private Equity at Northleaf, expressed pride in being part of CCM's enduring legacy. The investment aligns with Northleaf’s commitment to supporting established brands within the sports industry and fostering their growth moving forward. Flood emphasized that CCM's strong brand reputation, coupled with favorable industry trends, presents an excellent opportunity to generate attractive returns for investors.

The Partnership's Strategic Focus

Andreas Källström Säfweräng, a Partner at Altor, shared excitement about the collaboration with Northleaf. He noted that their collective resources and industry expertise would enable CCM to advance its strategic objectives and identify new paths for growth expansion. This partnership is expected to drive innovative initiatives and capitalize on emerging market trends in the hockey community.

Celebrating a Milestone

As CCM Hockey approaches its 125-year anniversary, the brand is entering a pivotal chapter in its historical journey. CEO Marrouane Nabih conveyed enthusiasm about the partnership, which should facilitate the implementation of CCM's ambitious growth plan. He considers the collaboration a critical element in enhancing product innovation while firmly committing to the promotion of hockey.

Northleaf's Reputation and Track Record

For over two decades, Northleaf has established itself as a respected investor in the private markets. The firm boasts a solid track record in various investment strategies, including co-investments, secondaries, structured capital, and primary investments. With over 150 private equity co-investments to its name, the partnership with CCM demonstrates Northleaf's effectiveness in aligning with top private equity sponsors to integrate and support high-quality mid-market businesses.

About Northleaf Capital Partners

Northleaf Capital Partners has successfully raised more than US$27 billion across a variety of private market commitments, focusing on private equity, private credit, and infrastructure investments. The firm serves a diversified clientele, which includes pension plans, endowments, foundations, and family offices. With a global workforce of over 275 professionals stationed in major cities worldwide, Northleaf is adept at sourcing, evaluating, and managing private market investments.

About Altor Equity Partners

Altor Equity Partners has carved a niche in the European investment landscape by raising in excess of EUR 11 billion since its inception. Their focus remains on investing in medium-sized companies, primarily within the Nordic and DACH regions. Established with a commitment to driving value through growth strategies and operational enhancements, Altor has supported numerous companies in reaching their full potential.

About CCM Hockey

CCM Hockey remains at the forefront of the sports equipment sector, particularly concerning hockey gear. With its headquarters in Montreal, CCM not only leads in hockey equipment, but it has also become synonymous with excellence in the skating industry through its subsidiary, Jackson Ultima. CCM's commitment to quality is reflected in its partnerships with professional players across leagues like the NHL, PWHL, and NCAA.

Frequently Asked Questions

What prompted Northleaf's investment in CCM Hockey?

Northleaf's investment in CCM is driven by the company's strong brand, significant growth potential, and the opportunity to innovate within the hockey equipment sector.

Who are the key partners in this investment?

Northleaf Capital Partners has partnered with Altor Equity Partners to support CCM Hockey's growth and strategic initiatives.

How does this investment benefit CCM Hockey?

The partnership is designed to accelerate CCM's growth strategy, allowing the company to explore new opportunities and innovate its product offerings.

What is CCM Hockey known for?

CCM Hockey is recognized as a leading designer and manufacturer of hockey equipment, providing products for many professional hockey players.

What historical milestones has CCM Hockey achieved?

CCM Hockey has a rich history dating back to 1899, and it is preparing to celebrate its 125-year anniversary, marking a significant achievement in the sports industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading